ctrl K

Frazier Lifesciences Acqu... (FLACU)

NASDAQ: FLACU · Real-Time Price · USD

9.50

0.23 (2.48%)

At close: Nov 22, 2022, 8:59 PM

Frazier Lifesciences Acquisition Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-5.08M	-3.16M	-1.47M	-1.37M	-1.04M	-670.14K	-364.9K	-127.66K
Interest Income	826.09K	120.66K	24.83K	16.16K	13.24K	11.47K	4.45K	n/a
Pretax Income	-3.64M	2.87M	2.75M	4.18M	3.12M	1.39M	2.69M	-126.81K
Net Income	-2.18M	6.82M	5.87M	5.57M	3.12M	1.39M	2.69M	-126.81K
Selling & General & Admin	5.02M	3.13M	1.47M	1.37M	1.03M	663.36K	358.13K	120.88K
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	120.88K	120.88K	120.88K	120.88K
Operating Expenses	5.02M	3.13M	1.47M	1.37M	1.03M	663.36K	358.13K	120.88K
Interest Expense	1.68M	-800.08K	24.83K	16.16K	13.24K	11.47K	4.45K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	5.02M	3.13M	1.47M	1.37M	1.03M	663.36K	358.13K	120.88K
Income Tax Expense	-1.46M	-3.95M	-3.13M	-1.39M	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	14.3M	14.3M	17.75M	17.75M	17.75M	3.95M	3.95M	3.11M
Shares Outstanding (Diluted)	14.3M	14.3M	17.75M	17.75M	17.75M	17.75M	13.8M	17.41M
EPS (Basic)	-0.22	0.38	0.08	0.61	0.44	0.34	0.67	-0.04
EPS (Diluted)	-0.22	0.38	0.33	0.35	0.22	0.12	0.19	-0.01
EBITDA	-3.62M	2.89M	2.77M	4.19M	3.14M	1.4M	2.7M	-126.81K
EBIT	2.33M	4.06M	2.77M	4.19M	3.26M	1.53M	2.82M	n/a
Depreciation & Amortization	1.46M	6.05M	4.24M	5.56M	4.17M	2.07M	3.06M	851.00